ARCHIVES

MGI Pharma, MethylGene Begin Phase II Trial Of MG98.

This article is from The Cancer Letter archive.

Vol. 27 No. 35 | September 28, 2001

Download PDF Visit The Full Archive

Related Articles

Arnold Brown Will Be Appointed NCI Director; Rauscher, Staff “Couldn’t Be More Pleased”

October 22, 1976

In Brief: Raub To Leave NIH For Science Office; Douros Dead At 60; ‘NEJM’ To Publish Aspirin Study

November 29, 1991

Stanford Group Working To Build ‘Superhighway’ To Synthesis Of Taxol

May 15, 1992

Funding Opportunities.

June 7, 2002

Patch-Lozenge Combination Best For Smoking Cessation

November 27, 2009

Xgeva Significantly Increases Bone Metastasis-Free Survival

May 27, 2011